KERN PHARMA

Kern Pharma is a Catalan pharmaceutical company that focuses on the manufacture of generic medicines. Founded in 1999, Gynea Laboratorios is headquartered in Barcelona and has a subsidiary in Chile. It employs more than 600 professionals and produces more than 100 million units of generic medicines per year. The company belongs to the Indukern group, a Spanish multinational with subsidiaries in 19 countries.

In addition to the production of medicines, the brand has been expanding its market niche with new products. Kern has been able to go beyond this, has come up with new formulations and has developed new areas such as women's health, aesthetic medicine, personal care and third-party production. In the area of gynaecology, it has also expanded its offerings with the creation of products for maternity, maturity and intimate protection. The brand is a recognised manufacturer of products for large companies. Kern Pharma is trusted by large companies that recommend its products for their reliability, competitiveness and manufacturing experience. They work for companies in Europe, Latin America and Asia.

The company has several divisions, through which they offer different treatments and products for the different needs of the users. Kern Pharma focuses on the development, manufacture and marketing of generic medicines; Consumer is the division created to provide pharmaceutical information and recommendations; Finisher, the health and sports nutrition line that the brand has created with the intention of targeting people who are committed to a healthy lifestyle, and Actafarma, a line of products aimed at self-care.